REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Celon S.A. (Poland)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Celon Pharma S.A. Profile Updated: November 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a successful marketing authorization holder for it products. A big advantage of Celon Pharma S.A. there is the strong research and development base that allows the company to create completely new classes of effective medicines. Research and development department of Celon Pharma S.A. consists of over 70 scientists, out of which ¼ has a PhD in molecular biology, pharmacy or chemistry.

Headquarters
ul. Ogrodowa 2A
Lomianki; Mazowieckie; Postal Code: 05-092

Contact Details: Purchase the Celon S.A. report to view the information.

Website: http://www.celonpharma.com

Basic Information
Total Employees:
Purchase the Celon S.A. report to view the information.
Outstanding Shares:
Purchase the Celon S.A. report to view the information.
Registered Capital:
Purchase the Celon S.A. report to view the information.
Financial Auditors:
Purchase the Celon S.A. report to view the information.
Incorporation Date:
October 25, 2012
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
55.86%
Purchase this report to view the information.
7.6%
Subsidiaries
Action For Development Of Research Sp. z o.o.
74.52%
Company Performance
Financial values in the chart are available after Celon S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-6.11%▼
Total operating revenue
-6.61%▼
Operating profit (EBIT)
-201.33%▼
EBITDA
-97.16%▼
Net Profit (Loss) for the Period
-273.81%▼
Total assets
-2.52%▼
Total equity
-1.52%▼
Operating Profit Margin (ROS)
-16.05%▼
Net Profit Margin
-16.75%▼
Return on Equity (ROE)
-3.8%▼
Debt to Equity Ratio
-1.35%▼
Quick Ratio
0.32%▲
Cash Ratio
0.26%▲

Similar companies

Zaklady Farmaceutyczne "Polpharma" S.A.
 
Lek S.A.
Bayer Sp. z o.o.
 
"Roche Polska" Sp. z o.o.
Teva Operations Poland Sp. z o.o.
 
Adamed Pharma S.A.
Biotee Polska Sp. z o.o.
 
Phytopharm Kleka S.A.
Bioton S.A.
 
"Martin Bauer Polska" Sp. z o.o.
Health-Med Sp. z o.o. sp. j.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo